Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE consortium studies1-4

Journal of Nutrition

Volumn 143, Issue 3, 2013, Pages 345-353

  Hruby, Adela ^a   Ngwa, Julius S ^b   Renström, Frida ^c,d,e   Wo jczynski, Mary K ^f   Ganna, Andrea ^g   Hallmans, Göran ^e   Houston, Denise K ^h   Jacques, Paul F ^a   Kanoni, Stavroula ^i,j   Lehtimäki, Terho ^k   Lemaitre, Rozenn N ^l   Manichaikul, Ani ^m   North, Kari E ⁿ   Ntalla, Ioanna ^o   Sonestedt, Emily ^d   Tanaka, Toshiko ^o   van Rooij, Frank J A ^p,q   Bandinelli, Stefania ^r   Djoussé, Luc ^s,t   Grigoriou, Efi ^j   Johansson, Ingegerd ^e   Lohman, Kurt K ^h   Pankow, James S ^u   Raitakari, Olli T ^v   Riserus, Ulf ^w   Yannakoulia, Mary ^j   Zillikens, M Carola ^p,q   Hassanali, Neelam ^x   Liu, Yongmei ^h   Mozaffarian, Dariush ^c,s   Papoutsakis, Constantina ^j   Syvänen, Ann Christine ^y   Uitterlinden, André G ^p,q   Viikari, Jorma ^z   Groves, Christopher J ^x   Lind, Albert Hofman ^p,q,y   Lind, Lars ^y   McCarthy, Mark I ^x,aa   Mikkilä̈, Vera ^ab   Mukamal, Kenneth ^ac   Franco, Oscar H ^p,q   Borecki, Ingrid B ^f   Cupples, L Adrienne ^b,ad   Dedoussis, George V ^j   Ferrucci, Luigi ^o   Hu, Frank B ^c   Ingelsson, Erik ^g   Kähönen, Mika ^ae   Kao, W H Linda ^af   Kritchevsky, Stephen B ^h   Orho Melander, Marju ^d   Prokopenko, Inga ^x,ag   Rotter, Jerome I ^ah   Siscovick, David S ^l,ai   Witteman, Jacqueline C M ^p,q   Franks, Paul W ^c,d,e   Meigs, James B ^aj   McKeown, Nicola M ^a   Nettleton, Jennifer A ^ak   more..

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d LUND UNIVERSITY   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^j HAROKOPIO UNIVERSITY   (Greece)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^l UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ IL   (United States)

^o NATIONAL INSTITUTE ON AGING   (United States)

^p ERASMUS MEDICAL CENTER   (Netherlands)

^q Netherlands Genomics Initiative   (Netherlands)

^r Geriatric Unit   (Italy)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t VETERANS AFFAIRS MEDICAL CENTER   (United States)

^u UNIVERSITY OF MINNESOTA   (United States)

^v UNIVERSITY OF TURKU   (Finland)

^w UPPSALA UNIVERSITY   (Sweden)

^x UNIVERSITY OF OXFORD   (United Kingdom)

^y UPPSALA UNIVERSITY   (Sweden)

^z TURKU UNIVERSITY HOSPITAL   (Finland)

^aa CHURCHILL HOSPITAL   (United Kingdom)

^ab UNIVERSITY OF HELSINKI   (Finland)

^ac BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^ad FRAMINGHAM HEART STUDY   (United States)

^ae TAMPERE UNIVERSITY HOSPITAL   (Finland)

^af JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah CEDARS SINAI MEDICAL CENTER   (United States)

^ai UNIVERSITY OF WASHINGTON   (United States)

^aj MASSACHUSETTS GENERAL HOSPITAL   (United States)

^ak UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MAGNESIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6;

AGE; ARTICLE; BODY MASS; CALORIC INTAKE; DIETARY INTAKE; GENE LOCUS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

BLOOD GLUCOSE; FEMALE; GENETIC LOCI; HUMANS; INSULIN; MAGNESIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRACE ELEMENTS; TRPM CATION CHANNELS;

EID: 84874705274     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.172049     Document Type: Article

References (40)

1. Shils ME, Shike M. Modern nutrition in health and disease. Philadelphia: Lippincott, Williams, & Wilkins; 2006.
2. Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, Hu FB. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr. 2003;22:533-8.
3. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR, He K. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care. 2010;33:2604-10.
4. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens. 1999;12:747-56.
5. Ma B, LawsonAB, Liese AD, Bell RA, Mayer-Davis EJ. Dairy,magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol. 2006;164:449-58.
6. Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PWF, Jacques PF. Magnesium intake is related to improved insulin homeostasis in the Framingham Offspring cohort. J Am Coll Nutr. 2006;25:486-92.
7. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care. 2004;27:59-65.
8. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR, Savage PJ.Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-82.
9. Dong J-Y, Xun P, He K, Qin L-Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34:2116-22.
10. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208-14.
11. Guerrero-Romero F, Rodríguez-Morán M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: doubleblind, randomized clinical trial. Eur J Clin Invest. 2011;41:405-10.
12. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A, Zebekakis PE, Pikilidou MI, Lasaridis AN. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit. 2010;16:CR307-12.
13. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects-a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011;13:281-4.
14. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Trevin{ogonek} o-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance: a double-blind placebocontrolled randomized trial. Diabetes Metab. 2004;30:253-8.
15. Yokota K, Kato M, Lister F, Ii H, Hayakawa T, Kikuta T, Kageyama S, Tajima N. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr. 2004;23:506S-9S.
16. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a metaanalysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050-6.
17. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105-16.
18. Meyer TE, Verwoert GC, Hwang S-J, Glazer NL, Smith AV, Van Rooij FJA, Ehret GB, Boerwinkle E, Felix JF, et al.; The Genetic Factors for Osteoporosis (GEFOS) Consortium. Meta-Analysis of Glucose and Insulin Related Traits Consortium (MAGIC): genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet. 2010;6:e1001045.
19. Nair AV, Hocher B, Verkaart S, Van Zeeland F, Pfab T, Slowinski T, Chen Y-P, Schlingmann KP, Schaller A, et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci USA. 2012;109:11324-9.
20. Song Y, Hsu Y-H, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet. 2009;10:4.
21. Romero JR, Castonguay AJ, Barton NS, Germer S, Martin M, Zee RYL. Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study. Transl Res. 2010;156:235-41.
22. Suárez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia. 1995;38:1262-70.
23. 2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res. 2010;23:5-18.
24. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert M-F, Ngwa J, Van Rooij FJA, Sonestedt E,Wojczynski MK, et al. Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent. Diabetes Care. 2010;33:2684-91.
25. Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557-60.
26. Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses. In: Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. Higgins JPT, Green S, editors. The Cochrane Collaboration; 2011 [cited 2012 Oct 22]. Available from: www.cochrane-handbook.org.
27. Kanoni S, Nettleton JA, Hivert M-F, Ye Z, Van Rooij FJA, Shungin D, Sonestedt E, Ngwa JS, Wojczynski MK, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant. Diabetes. 2011;60:2407-16.
28. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142:1304-13.
29. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, Hu FB. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140:1-8.
30. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care. 2006;29:398-403.
31. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477-8.
32. Tuomilehto J. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA. 2004;291:1213-9.
33. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med. 2004;255:89-95.
34. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48:927-40.
35. Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public Health Nutr. 2012; 15(4):693-701.
36. Palla L, Higgins JPT, Wareham NJ, Sharp SJ. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol. 2010;171:1225-32.
37. Franks PW. Gene 3 environment interactions in type 2 diabetes. Curr Diab Rep. 2011;11:552-61.
38. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, Butch A, Liu S. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr. 2011; 93:463-73.
39. Gow IF, O'Donnell M, Flint L, Flapan AD. Infusion of Mg in humans acutely reduces serum insulin levels: a pilot study. Magnes Res. 2011;24:189-95.
40. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, Donofrio F. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55:1161-7.